Cargando…

Observational Study on Unhealthy Eating Behavior and the Effect of Sodium-Glucose Cotransporter 2 Inhibitors: The Luseogliflozin Ehime Diabetes Study

INTRODUCTION: Luseogliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor. Unhealthy eating behavior is associated with diabetes, hypertension, and obesity. However, evidence regarding the effect of medications, including SGLT2 inhibitors, on unhealthy eating behavior is limited. This study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Furukawa, Shinya, Miyake, Teruki, Miyaoka, Hiroaki, Matsuura, Bunzo, Hiasa, Yoichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9076764/ https://www.ncbi.nlm.nih.gov/pubmed/35426601 http://dx.doi.org/10.1007/s13300-022-01261-9

Ejemplares similares

Additional Effect of Luseogliflozin on Semaglutide in Nonalcoholic Steatohepatitis Complicated by Type 2 Diabetes Mellitus: An Open-Label, Randomized, Parallel-Group Study
por: Miyake, Teruki, et al.
Publicado: (2022)

Nocturia and prevalence of erectile dysfunction in Japanese patients with type 2 diabetes mellitus: The Dogo Study
por: Furukawa, Shinya, et al.
Publicado: (2016)

Physical activity and prevalence of erectile dysfunction in Japanese patients with type 2 diabetes mellitus: The Dogo Study
por: Minami, Hisaka, et al.
Publicado: (2017)

Hyperuricemia Is a Risk Factor for the Onset of Impaired Fasting Glucose in Men with a High Plasma Glucose Level: A Community-Based Study
por: Miyake, Teruki, et al.
Publicado: (2014)

Dietary intake habits and the prevalence of nocturia in Japanese patients with type 2 diabetes mellitus
por: Furukawa, Shinya, et al.
Publicado: (2017)

Macrovascular Complications and Prevalence of Urgency Incontinence in Japanese Patients with Type 2 Diabetes Mellitus: The Dogo Study
por: Furukawa, Shinya, et al.
Publicado: (2017)

Cigarette smoking is a risk factor for the onset of fatty liver disease in nondrinkers: A longitudinal cohort study
por: Okamoto, Masashi, et al.
Publicado: (2018)

Insulin‐like growth factor‐1 is inversely associated with liver fibrotic markers in patients with type 2 diabetes mellitus
por: Miyauchi, Shozo, et al.
Publicado: (2019)

Ipragliflozin Ameliorates Liver Damage in Non-alcoholic Fatty Liver Disease
por: Miyake, Teruki, et al.
Publicado: (2018)

Effects of Motilin Receptor Agonists and Ghrelin in Human motilin receptor Transgenic Mice
por: Kawamura, Tomoe, et al.
Publicado: (2019)

Effect of the sodium–glucose cotransporter 2 inhibitor luseogliflozin on pancreatic beta cell mass in db/db mice of different ages
por: Takahashi, Kiyohiko, et al.
Publicado: (2018)

The Serum Creatinine Level Might Be Associated with the Onset of Impaired Fasting Glucose: A Community-based Longitudinal Cohort Health Checkup Study
por: Yoshida, Naohiko, et al.
Publicado: (2018)

The sodium-glucose cotransporter 2 inhibitor luseogliflozin can suppress muscle atrophy in Db/Db mice by suppressing the expression of foxo1
por: Okamura, Takuro, et al.
Publicado: (2019)

Relationship between urine pH and abnormal glucose tolerance in a community‐based study
por: Yoshida, Sakiko, et al.
Publicado: (2017)

Sodium‐glucose cotransporter 2 inhibitor luseogliflozin improves glycaemic control, assessed by continuous glucose monitoring, even on a low‐carbohydrate diet
por: Nishimura, R., et al.
Publicado: (2016)

B cell activating factor in obesity is regulated by oxidative stress in adipocytes
por: Tada, Fujimasa, et al.
Publicado: (2013)

Factors Influencing Change in Serum Uric Acid After Administration of the Sodium‐Glucose Cotransporter 2 Inhibitor Luseogliflozin in Patients With Type 2 Diabetes Mellitus
por: Chino, Yukihiro, et al.
Publicado: (2021)

Clinical implication of blood glucose monitoring in general dental offices: the Ehime Dental Diabetes Study
por: Harase, Tadahiro, et al.
Publicado: (2015)

Low Urine pH Is Associated with Non-alcoholic Fatty Liver Disease: A Community-based Cross-sectional Study
por: Miyake, Teruki, et al.
Publicado: (2018)

Depletion of B cell-activating factor attenuates hepatic fat accumulation in a murine model of nonalcoholic fatty liver disease
por: Nakamura, Yoshiko, et al.
Publicado: (2019)

Longitudinal impact of dapagliflozin treatment on ventricular repolarization heterogeneity in patients with type 2 diabetes
por: Sato, Tatsuya, et al.
Publicado: (2019)

The inverse association between unhealthy eating habit and mucosal healing among patients with ulcerative colitis
por: Furukawa, Shinya, et al.
Publicado: (2021)

Overall Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitor Luseogliflozin Versus Dipeptidyl-Peptidase 4 Inhibitors: Multicenter, Open-Label, Randomized-Controlled Trial (J-SELECT study)
por: Sugawara, Masahiro, et al.
Publicado: (2023)

Association Between Eating Behavior, Frequency of Meals, and Functional Dyspepsia in Young Japanese Population
por: Yamamoto, Yasunori, et al.
Publicado: (2022)

Relationship between body composition and the histology of non‐alcoholic fatty liver disease: a cross‐sectional study
por: Miyake, Teruki, et al.
Publicado: (2021)

Quantitative imaging of fibrotic and morphological changes in liver of non-alcoholic steatohepatitis (NASH) model mice by second harmonic generation (SHG) and auto-fluorescence (AF) imaging using two-photon excitation microscopy (TPEM)
por: Yamamoto, Shin, et al.
Publicado: (2016)

Nonalcoholic fatty liver disease is a risk factor for glucose intolerance onset in men regardless of alanine aminotransferase status
por: Miyake, Teruki, et al.
Publicado: (2021)

Comparative Study of Hepatocellular Carcinoma in Shikoku, Japan: a Study of 198 Autopsy Cases in Tokushima and Ehime Prefectures
por: Akagi, Go, et al.
Publicado: (1988)

Disease activity and erectile dysfunction in Japanese patients with ulcerative colitis
por: Furukawa, Shinya, et al.
Publicado: (2023)

Sodium–glucose cotransporter 2 inhibitor‐induced changes in body composition and simultaneous changes in metabolic profile: 52‐week prospective LIGHT (Luseogliflozin: the Components of Weight Loss in Japanese Patients with Type 2 Diabetes Mellitus) Study
por: Sasaki, Takashi, et al.
Publicado: (2018)

Role of B Cell-Activating Factor in Fibrosis Progression in a Murine Model of Non-Alcoholic Steatohepatitis
por: Kanemitsu-Okada, Kozue, et al.
Publicado: (2023)

Comparison of Regional Differences in Health Indicators and Standard Mortality Ratio for Stroke in Subjects in Ehime Prefecture
por: Tamura, Yuka, et al.
Publicado: (2013)

Serological survey of Peaton virus among wild boars (Sus scrofa) in Ehime Prefecture, Japan
por: YOSHIZAWA, Nobuki
Publicado: (2023)

Effects of luseogliflozin treatment on hyperglycemia-induced muscle atrophy in rats
por: Xie, Keyu, et al.
Publicado: (2023)

Treatment on the Spleen Prevents the Progression of Secondary Sarcopenia in Patients With Liver Cirrhosis
por: Hirooka, Masashi, et al.
Publicado: (2020)

Fatty liver with metabolic disorder, such as metabolic dysfunction‐associated fatty liver disease, indicates high risk for developing diabetes mellitus
por: Miyake, Teruki, et al.
Publicado: (2022)

Plasma Fatty Acid Composition Is Associated with Histological Findings of Nonalcoholic Steatohepatitis
por: Miyake, Teruki, et al.
Publicado: (2022)

A year‐round evidence‐based medicine‐learning course organized by medical students at Ehime University
por: Watanabe, Haruka, et al.
Publicado: (2017)

Combined evaluation of Fibrosis‐4 index and fatty liver for stratifying the risk for diabetes mellitus
por: Todo, Yasuhiko, et al.
Publicado: (2022)

Tubulointerstitial Nephritis after Using a Sodium-glucose Cotransporter 2 Inhibitor
por: Konta, Yusuke, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l7pvfetsfnagll1h89ifu2fn3n